Sponsor:
Olatec Therapeutics LLC
Code:
NCT05658575
Conditions
Acute Gout Flare
Gout Attack
Gout Flare
Gouty Arthritis
Gout
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Dapansutrile
Placebo Tablet
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2025-06-01. This information was provided to ClinicalTrials.gov by Olatec Therapeutics LLC on 2025-05-29.